ALPHA IVF GROUP BERHAD

ALPHA IVF GROUP BERHAD stands as one of Malaysia’s leading fertility care specialists — a company at the forefront of reproductive medicine and advanced healthcare innovation.

Established in 2011, the Group has grown into a prominent regional fertility care provider, operating specialised centres across Malaysia and Singapore while serving patients from around the world. Through continuous investment in reproductive science, embryology, and precision-driven technologies, Alpha IVF became recognised for its high treatment success rates and advanced clinical methodologies.

Today, the Group positions itself among the region’s leading assisted reproductive technology providers, contributing not only to the advancement of fertility medicine, but also to the growing role of Malaysia as a destination for specialised healthcare services.

Founder:

Dato’ Dr. Colin Lee Soon Soo

Current Leadership:

Group Managing Director: Dato’ Dr. Colin Lee

The leadership continues to guide the Group with a vision centred on advancing fertility science, improving reproductive outcomes, and helping families achieve the dream of parenthood through technology-driven healthcare solutions.

Some healthcare institutions are built around services — Alpha IVF was built around hope.

In 2011, Dato’ Dr. Colin Lee established Alpha Fertility Centre with a clear objective: to improve fertility treatment success rates through science, precision, and innovation. At the time, fertility care often carried uncertainty, inconsistent clinical outcomes, and limited integration of advanced technologies. Alpha IVF approached the field differently — treating fertility medicine as a highly system-driven discipline that combined medical expertise, embryology, laboratory precision, and continuous technological advancement.

Beginning from a single centre in Selangor, the organisation focused heavily on pushing scientific boundaries within assisted reproductive technology. The Group invested in advanced embryo monitoring systems, preimplantation genetic testing, AI-assisted embryo analysis, and data-driven fertility methodologies aimed at improving treatment outcomes.

As clinical success rates strengthened, so did the Group’s international reputation. Patients increasingly travelled from across Malaysia, Asia, and other regions seeking specialised fertility care. The expansion into Penang and Singapore marked a major transition — evolving Alpha IVF from a standalone clinic into a broader regional fertility network.

From a specialised medical centre to a life-changing healthcare institution, Alpha IVF’s journey reflects a mission that extends beyond medicine itself — restoring possibility where hope once felt uncertain.

Core Activities:

• In-vitro fertilisation (IVF) and assisted reproductive treatments

• Genetic testing and embryo screening (PGT)

• Fertility diagnostics and specialist consultation

• Cryopreservation of eggs, sperm, and embryos

The Group focuses on integrating medical expertise with advanced laboratory technologies and precision-based reproductive science to improve fertility outcomes. Through continuous research, technological adoption, and personalised treatment planning, Alpha IVF positions itself as a technology-driven fertility healthcare provider.

Notable Offerings Include:

• IVF and ICSI fertility treatments

• Preimplantation genetic testing (PGT)

• AI-assisted embryo selection and monitoring systems

• Fertility diagnostics and reproductive consultation services

These offerings position Alpha IVF as one of the leading providers of advanced reproductive healthcare and fertility technology solutions within the region.

2011 – Establishment of Alpha Fertility Centre

2017 – Expansion into Penang through Genesis IVF Centre

2019 – Expansion into Singapore operations

2020s – Adoption and integration of AI-assisted reproductive technologies and advanced fertility systems

2024 – Recognition through healthcare excellence and innovation-related awards

Alpha IVF has contributed significantly to the advancement of reproductive healthcare by improving fertility treatment success rates through technological innovation and precision-based medical systems.

The Group helped position Malaysia as a growing regional hub for reproductive medicine and fertility care, attracting international patients seeking advanced assisted reproductive treatments. Its integration of AI technologies, embryo screening systems, and genetic testing further contributed to raising industry standards within fertility science and reproductive healthcare.

Beyond medical outcomes, Alpha IVF’s work has impacted thousands of families by supporting the journey toward parenthood through specialised healthcare solutions grounded in science and compassion.

Today, ALPHA IVF GROUP BERHAD stands as a guardian of new beginnings — a testament to how science, compassion, and persistence can transform uncertainty into possibility.

From a single fertility centre in Selangor to a recognised regional reproductive healthcare group, the company’s journey reflects the convergence of medical innovation and human hope. Its continued advancement within fertility science demonstrates how specialised healthcare institutions can profoundly shape lives, families, and future generations.